首页 | 本学科首页   官方微博 | 高级检索  
     

青光眼与Th1、Th2相关细胞因子研究进展
引用本文:尚欢. 青光眼与Th1、Th2相关细胞因子研究进展[J]. 中华实验眼科杂志, 2017, 0(11): 1052-1056. DOI: 10.3760/cma.j.issn.2095-0160.2017.11.020
作者姓名:尚欢
作者单位:100191,北京大学第三医院眼科
基金项目:国家自然科学基金项目(81670851),首都市民健康项目培育项目(Z151100003915143),National Natural Science Foundation of China(81670851),Fund of the Capital Public Health Project(Z151100003915143)
摘    要:青光眼是导致不可逆盲的首要原因,包括视野缺损和视神经的慢性退行性病变,如视网膜神经节细胞(RGCs)的凋亡和视神经轴突的逐步缺失.目前普遍认为高眼压是青光艰的主要危险因素,降低眼压是减缓青光眼发生和发展的首选治疗方法.近年来发现免疫因素是青光眼视神经损害的非压力依赖性危险因素之一.大部分免疫,甚至非免疫性生物效应都通过细胞因子来调控,而CD4+辅助性T细胞是细胞因子产生和调节的主要来源,其中Th1和Th2相关细胞因子在青光眼的发病机制中起着不可或缺的作用,并关系着RGCs的存活和凋亡.本文就近年Th1和Th2主要的相关细胞因子及Th1/Th2平衡与青光眼潜在关系的研究进展进行综述.

关 键 词:青光眼  细胞因子  CD4%2B辅助性T细胞  视神经损伤

Research progress of the related cytokines of Th1 and Th2 on glaucoma
Abstract:Glaucoma is a leading cause of irreversible blindness,which includes visual field defects and chronic degenerative diseases of the optic nerve,such as apoptosis of the retinal ganglion cells (RGCs) and progressive loss of optic nerve axons.Elevated intraocular pressure is the primary risk factor for glaucoma,and lowering intraocular pressure is the first choice of treatment for slowing the development of glaucoma.It has recently been found that immunological factors are one of the non-stress-dependent risk factors for optic nerve damage in glaucoma,while most of the immune and non-immune biological effects are regulated by cytokines.CD4+ helper T cells are the major sources of cytokines.Thl and Th2-related cytokines play an essential role in the pathogenesis of glaucoma and related with the survival and apoptosis of RGCs.In this review,we discussed the potential relationship between Th1/Th2-related cytokines and glaucoma.
Keywords:Glaucoma  Cytokines  CD4+ helper T cells  Optic nerve injury
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号